Insider Transactions for Intra-Cellular Therapies, Inc. (ITCI)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorMar 20, 2024Option Exercise$18.5620,000371,20099,235Mar 22, 2024, 04:12 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 07, 2024Sale$66.5040,7122,707,2771,059,063Mar 11, 2024, 08:33 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 11, 2024Sale$65.2120,5651,341,1231,056,333Mar 11, 2024, 08:33 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance, CFOMar 10, 2024Option Exercise$56.734,539257,4974,539Mar 11, 2024, 08:33 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance, CFOMar 11, 2024Sale$65.9610,121667,5871,129Mar 11, 2024, 08:33 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance, CFOMar 07, 2024Sale$66.6013,132874,5606,618Mar 11, 2024, 08:33 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselMar 07, 2024Sale$66.1513,132868,698220Mar 11, 2024, 08:32 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselMar 11, 2024Sale$65.977,345484,5371,238Mar 11, 2024, 08:32 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerMar 07, 2024Sale$66.5713,132874,17934,196Mar 11, 2024, 08:31 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerMar 11, 2024Sale$65.617,345481,93132,742Mar 11, 2024, 08:31 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.EVP, Chief Medical OfficerMar 07, 2024Sale$66.566,450429,30818,892Mar 11, 2024, 08:31 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.EVP, Chief Medical OfficerMar 11, 2024Sale$65.593,712243,48221,336Mar 11, 2024, 08:31 PM
ITCIIntra-Cellular Therapies, Inc.VAN NOSTRAND ROBERT LDirectorFeb 27, 2024Sale$45.7540,0001,829,85029,611Feb 28, 2024, 07:41 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselFeb 26, 2024Sale$69.537,907549,7847,607Feb 27, 2024, 08:00 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance, CFOFeb 26, 2024Sale$59.4719,2191,142,9487,155Feb 27, 2024, 08:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 26, 2024Sale$69.7922,5901,576,4641,072,299Feb 27, 2024, 07:59 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.EVP, Chief Medical OfficerFeb 26, 2024Sale$70.174,112288,53412,200Feb 27, 2024, 07:58 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerFeb 26, 2024Sale$70.137,907554,49137,407Feb 27, 2024, 07:58 PM
ITCIIntra-Cellular Therapies, Inc.MARCUS JOEL SDirectorFeb 26, 2024Sale$57.1863,0853,606,93265,990Feb 27, 2024, 07:57 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselFeb 02, 2024Sale$66.4211,860787,719714Feb 05, 2024, 06:13 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 02, 2024Sale$67.0733,8852,272,6931,067,759Feb 05, 2024, 06:10 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerFeb 02, 2024Sale$67.1511,860796,36736,604Feb 05, 2024, 06:07 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance, CFOFeb 02, 2024Sale$66.6211,183745,037185Feb 05, 2024, 06:05 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.EVP, Chief Medical OfficerFeb 02, 2024Sale$67.196,167414,3559,540Feb 05, 2024, 06:02 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 16, 2024Sale$42.05150,7226,338,5691,125,670Jan 18, 2024, 07:47 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 17, 2024Sale$41.5596,1683,995,7581,098,393Jan 18, 2024, 07:47 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 18, 2024Sale$41.03135,8345,572,9291,118,226Jan 18, 2024, 07:47 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselJan 11, 2024Option Exercise$40.22100,0004,021,74950,000Jan 12, 2024, 06:02 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.EVP, Chief Medical OfficerJan 02, 2024Sale$45.24124,5645,634,65662,282Jan 04, 2024, 07:54 PM
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorDec 31, 2023Option Exercise$71.6225117,97779,235Jan 03, 2024, 06:46 PM
ITCIIntra-Cellular Therapies, Inc.VAN NOSTRAND ROBERT LDirectorDec 31, 2023Option Exercise$71.62765,4439,611Jan 03, 2024, 06:43 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.EVP, Chief Medical OfficerDec 13, 2023Sale$65.0021,2621,382,0300Dec 15, 2023, 05:01 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselNov 13, 2023Sale$33.73100,0003,372,83250,000Nov 14, 2023, 05:33 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerNov 06, 2023Sale$43.3769,1472,998,64272,093Nov 08, 2023, 05:31 PM
ITCIIntra-Cellular Therapies, Inc.VAN NOSTRAND ROBERT LDirectorSep 30, 2023Option Exercise$52.091055,4699,535Oct 02, 2023, 05:30 PM
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorSep 30, 2023Option Exercise$52.0934517,97178,984Oct 02, 2023, 05:29 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOSep 18, 2023Sale$53.7655,5872,988,2131,122,841Sep 19, 2023, 08:40 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOSep 19, 2023Sale$54.1744,4132,405,8521,050,309Sep 19, 2023, 08:40 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerAug 07, 2023Option Exercise$38.69110,6004,279,114100,639Aug 09, 2023, 06:05 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.EVP, Chief Medical OfficerJul 17, 2023Sale$65.001,842119,73021,262Jul 20, 2023, 05:47 PM
ITCIIntra-Cellular Therapies, Inc.VAN NOSTRAND ROBERT LDirectorJun 30, 2023Option Exercise$63.32855,3829,430Jul 05, 2023, 04:29 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOJun 14, 2023Sale$53.14163,7088,698,64781,854Jun 16, 2023, 05:05 PM
ITCIIntra-Cellular Therapies, Inc.VAN NOSTRAND ROBERT LDirectorApr 17, 2023Option Exercise$38.0320,000760,50019,345Apr 19, 2023, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorMar 31, 2023Option Exercise$54.1531316,94978,360Apr 04, 2023, 05:01 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerMar 28, 2023Sale$54.3115,604847,38055,522Mar 30, 2023, 05:08 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.EVP, Chief Medical OfficerMar 13, 2023Sale$45.047,344330,79423,450Mar 13, 2023, 07:36 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerMar 10, 2023Sale$43.348,550370,55759,157Mar 13, 2023, 07:35 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerMar 13, 2023Sale$44.983,758169,04261,366Mar 13, 2023, 07:35 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselMar 10, 2023Sale$43.1016,708720,0862,500Mar 13, 2023, 07:34 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselMar 13, 2023Sale$44.947,344330,007476Mar 13, 2023, 07:34 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOMar 10, 2023Sale$43.0615,663674,4172,700Mar 13, 2023, 07:32 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOMar 13, 2023Sale$44.935,582250,808258Mar 13, 2023, 07:32 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 10, 2023Sale$43.1541,7701,802,5661,137,114Mar 13, 2023, 07:31 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 13, 2023Option Exercise$24.4240,565990,4751,150,309Mar 13, 2023, 07:31 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerMar 01, 2023Sale$50.017,241362,12249,199Mar 03, 2023, 07:03 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerFeb 24, 2023Sale$47.124,046190,64856,440Feb 27, 2023, 08:03 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.SVP, Chief Medical OfficerFeb 24, 2023Sale$47.147,906372,68923,104Feb 27, 2023, 08:02 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselFeb 24, 2023Sale$47.037,906371,8190Feb 27, 2023, 08:01 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOFeb 24, 2023Sale$47.037,455350,6090Feb 27, 2023, 08:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 24, 2023Sale$22.0652,5901,160,2081,130,309Feb 27, 2023, 07:59 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerFeb 21, 2023Sale$47.013,898183,24653,338Feb 22, 2023, 08:05 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.SVP, Chief Medical OfficerFeb 21, 2023Sale$46.848,354391,30424,785Feb 22, 2023, 08:04 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselFeb 21, 2023Sale$46.8411,139521,6991,843Feb 22, 2023, 08:03 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOFeb 17, 2023Sale$31.28107,9363,376,47653,968Feb 22, 2023, 08:02 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOFeb 21, 2023Sale$46.8210,443488,8911,794Feb 22, 2023, 08:02 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 21, 2023Sale$46.8327,8481,304,0001,105,262Feb 22, 2023, 08:01 PM
ITCIIntra-Cellular Therapies, Inc.VAN NOSTRAND ROBERT LDirectorDec 30, 2022Option Exercise$52.92975,1339,250Jan 03, 2023, 04:19 PM
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorDec 30, 2022Option Exercise$52.9232116,98778,047Jan 03, 2023, 04:18 PM
ITCIIntra-Cellular Therapies, Inc.MARCUS JOEL SDirectorDec 19, 2022Sale$50.825,000254,10029,233Dec 21, 2022, 04:06 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEODec 13, 2022Sale$55.0033,0831,819,5651,100,309Dec 15, 2022, 07:01 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselDec 01, 2022Sale$34.60100,0003,460,01450,000Dec 02, 2022, 07:14 PM
ITCIIntra-Cellular Therapies, Inc.MARCUS JOEL SDirectorNov 07, 2022Sale$52.3010,000523,02339,233Nov 08, 2022, 04:12 PM
ITCIIntra-Cellular Therapies, Inc.VAN NOSTRAND ROBERT LDirectorSep 30, 2022Option Exercise$46.531105,1189,153Oct 05, 2022, 04:04 PM
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorSep 30, 2022Option Exercise$46.5336516,98377,726Oct 04, 2022, 04:11 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOSep 21, 2022Sale$30.55130,3283,981,49365,164Sep 23, 2022, 09:01 PM
ITCIIntra-Cellular Therapies, Inc.VAN NOSTRAND ROBERT LDirectorAug 11, 2022Sale$34.8960,0002,093,47539,043Aug 12, 2022, 06:09 PM
ITCIIntra-Cellular Therapies, Inc.MARCUS JOEL SDirectorAug 11, 2022Sale$59.2210,000592,20044,233Aug 12, 2022, 06:05 PM
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorJun 30, 2022Option Exercise$57.0828916,49677,361Jul 05, 2022, 04:06 PM
ITCIIntra-Cellular Therapies, Inc.MARCUS JOEL SDirectorMay 12, 2022Sale$55.0010,000550,00054,233May 13, 2022, 05:24 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerApr 08, 2022Sale$38.55172,6966,657,261131,687Apr 08, 2022, 06:56 PM
ITCIIntra-Cellular Therapies, Inc.VAN NOSTRAND ROBERT LDirectorMar 31, 2022Option Exercise$61.191267,7108,935Apr 04, 2022, 04:11 PM
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorMar 31, 2022Option Exercise$61.1925715,72677,072Apr 04, 2022, 04:08 PM
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorMar 16, 2022Sale$59.2764,5343,824,827205,984Mar 18, 2022, 08:12 PM
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorMar 17, 2022Sale$60.33141,4998,536,646135,549Mar 18, 2022, 08:12 PM
ITCIIntra-Cellular Therapies, Inc.RIGGS RORY BDirectorMar 18, 2022Sale$61.1820,6371,262,50515,736Mar 18, 2022, 08:12 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 09, 2022Option Exercise$2.8438,925110,5471,133,392Mar 10, 2022, 04:13 PM
ITCIIntra-Cellular Therapies, Inc.MARCUS JOEL SDirectorMar 08, 2022Sale$52.6815,000790,15038,980Mar 09, 2022, 09:49 PM
ITCIIntra-Cellular Therapies, Inc.MARCUS JOEL SDirectorMar 07, 2022Sale$54.525,000272,60043,980Mar 09, 2022, 09:49 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.Chief Medical OfficerMar 02, 2022Sale$56.984,177238,00526,964Mar 04, 2022, 06:05 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.Chief Medical OfficerMar 04, 2022Sale$55.523,860214,30723,104Mar 04, 2022, 06:05 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.Chief Medical OfficerFeb 24, 2022Sale$52.274,046211,46833,984Feb 25, 2022, 07:09 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerFeb 24, 2022Sale$52.217,906412,81050,585Feb 25, 2022, 07:08 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselFeb 24, 2022Sale$51.987,906410,9334,188Feb 25, 2022, 07:06 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOFeb 24, 2022Sale$51.977,454387,3494,083Feb 25, 2022, 07:04 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 24, 2022Sale$51.9822,5891,174,0741,105,807Feb 25, 2022, 07:01 PM
ITCIIntra-Cellular Therapies, Inc.Durgam Suresh K.Chief Medical OfficerFeb 22, 2022Sale$55.294,177230,95828,638Feb 23, 2022, 07:08 PM
ITCIIntra-Cellular Therapies, Inc.Neumann MarkEVP, Chief Commercial OfficerFeb 22, 2022Sale$55.2911,139615,82749,946Feb 23, 2022, 07:07 PM
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP and General CounselFeb 22, 2022Sale$55.4011,139617,1004,550Feb 23, 2022, 07:05 PM
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOFeb 22, 2022Sale$55.4010,443578,5064,627Feb 23, 2022, 07:02 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 22, 2022Sale$55.3927,8471,542,4131,107,134Feb 23, 2022, 07:00 PM